cardiology

Heart disease and chronic kidney disease can accelerate one another, but new guidelines say simple screening and early treatment could substantially reduce the risks. Blood and urine tests, combined with proven heart and kidney therapies, may help catch problems sooner and prevent serious complications.

Low-carbohydrate diets can affect cholesterol in very different ways. Some people see little change in their LDL cholesterol, while others experience a sharp rise even when they are following a similar eating plan. New research from Stanford University School of Medicine suggests that genetics may help explain part of this difference. The findings were presented […] The post Why Low-Carb Diets Ra…

A major trial hints that better blood pressure control may offer an unexpected benefit for brain health.

A closely watched cardiovascular drug from Novartis failed in a pivotal study, the company said Friday, a major blow to the firm.

Despite the therapeutic promise of natural plants in preclinical models, their clinical value for heart failure (HF) remains unconfirmed and requires rigorous validation through well-designed trials. HF severely impairs quality of life, and natural plant therapies—known for their multi-metabolites and multi-target effects—have been explored as potential treatments via modulation of autophagy, inh…

Systemic Lupus Erythematosus (SLE), commonly known as lupus, is an autoimmune disease that causes inflammation across the body, including in the kidneys, lungs, and other organs. People with lupus are at a much higher risk of cardiovascular disease compared to the general population, and young women with lupus are up to 50 times more likely to have a heart attack than young women without lupus.

People do not have to wait until after a heart attack or stroke to benefit from very intensive cholesterol treatment, according to new research. An analysis of a major clinical trial found that high-risk adults taking evolocumab alongside standard cholesterol medicines had fewer deaths than those receiving standard treatment plus a placebo. The research comes […] The post Lowering ‘Bad’ Cholester…